MCNAY JOSEPH C 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Jul 9, 2018
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Conversion
Convertible Promissory Note (right to buy)
2018-07-05−1,044,560→ 0 totalExercise: $0.06From: 2013-07-05Exp: 2018-07-04→ Common Stock (1,044,560 underlying) - Conversion
Common Stock
2018-07-05$0.06/sh+1,044,560$62,674→ 3,912,722 total
Footnotes (1)
- [F1]The Convertible Promissory Note in the principal amount of $50,000 accrued $12,673.61 in interest and both principal and interest were converted into 1,044,560 shares of common stock at a conversion price of $0.06 per share.